Page 10 - MTMP_Magazine
P. 10
8
On November 27, Israel-based Teva Pharmaceuticals announced the recall
of all lots of Amlodine and Amlodine/Hydrochlorothiazide because the active ingredient, valsartan, was found to contain high levels of an industrial chemical known to cause cancer.
The contaminated valsartan was a product of Mylan Pharmaceutical’s India-based operation.
It is not the first time Mylan has had problems with NDEA contamination. Only days earlier, the global pharmaceutical giant issued a recall for 15 lots
of anti-hypertensive and heart medications
containing valsartan due to trace amounts of NDEA. On November 19, the European Medicines Agency (EMA) issued an order that effectively prohibits the use of valsartan from Mylan India in medications sold and used in the EU.
FEATURED ARTICLE: VALSARTAN
Heart Medication Found to
Be Contaminated with Jet Fuel
